Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

194 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Chronic lymphocytic leukemia (CLL)-Then and now.
Rai KR, Jain P. Rai KR, et al. Am J Hematol. 2016 Mar;91(3):330-40. doi: 10.1002/ajh.24282. Am J Hematol. 2016. PMID: 26690614 Review.
Prognostic factors in chronic lymphocytic leukemia.
Rai KR, Montserrat E. Rai KR, et al. Semin Hematol. 1987 Oct;24(4):252-6. Semin Hematol. 1987. PMID: 3686047
Chronic lymphocytic leukemia.
Rai KR, Sawitsky A, Jagathambal K, Gartenhaus W, Phillips E. Rai KR, et al. Med Clin North Am. 1984 May;68(3):697-711. doi: 10.1016/s0025-7125(16)31123-3. Med Clin North Am. 1984. PMID: 6379339 Review.
Distinct characteristics of lymphokine-activated killer (LAK) cells derived from patients with B-cell chronic lymphocytic leukemia (B-CLL). A factor in B-CLL serum promotes natural killer cell-like LAK cell growth.
Santiago-Schwarz F, Panagiotopoulos C, Sawitsky A, Rai KR. Santiago-Schwarz F, et al. Among authors: rai kr. Blood. 1990 Oct 1;76(7):1355-60. Blood. 1990. PMID: 2207313
Guidelines for protocol studies in chronic lymphocytic leukemia.
Silver RT, Sawitsky A, Rai K, Holland JF, Glidewell O. Silver RT, et al. Am J Hematol. 1978;4(4):343-58. doi: 10.1002/ajh.2830040406. Am J Hematol. 1978. PMID: 717396
Plasminogen-dependent fibrinolytic activity in normal human lymphocytes: diminished lymphocyte plasminogen activator in chronic lymphocytic leukemia.
Zucker S, Mehling K, Rai K. Zucker S, et al. Am J Hematol. 1985 Aug;19(4):373-86. doi: 10.1002/ajh.2830190408. Am J Hematol. 1985. PMID: 3927713
BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia.
Chen SS, Chang BY, Chang S, Tong T, Ham S, Sherry B, Burger JA, Rai KR, Chiorazzi N. Chen SS, et al. Among authors: rai kr. Leukemia. 2016 Apr;30(4):833-43. doi: 10.1038/leu.2015.316. Epub 2015 Nov 9. Leukemia. 2016. PMID: 26582643 Free PMC article.
Management guidelines for the use of alemtuzumab in chronic lymphocytic leukemia.
Osterborg A, Foà R, Bezares RF, Dearden C, Dyer MJ, Geisler C, Lin TS, Montillo M, van Oers MH, Wendtner CM, Rai KR. Osterborg A, et al. Among authors: rai kr. Leukemia. 2009 Nov;23(11):1980-8. doi: 10.1038/leu.2009.146. Epub 2009 Jul 23. Leukemia. 2009. PMID: 19626051 Review.
Somatic CLL mutations occur at multiple distinct hematopoietic maturation stages: documentation and cautionary note regarding cell fraction purity.
Marsilio S, Khiabanian H, Fabbri G, Vergani S, Scuoppo C, Montserrat E, Shpall EJ, Hadigol M, Marin P, Rai KR, Rabadan R, Devereux S, Pasqualucci L, Chiorazzi N. Marsilio S, et al. Among authors: rai kr. Leukemia. 2018 Apr;32(4):1041-1044. doi: 10.1038/leu.2017.343. Epub 2017 Dec 5. Leukemia. 2018. PMID: 29203856 Free PMC article. No abstract available.
Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia.
Gupta N, Kavuru S, Patel D, Janson D, Driscoll N, Ahmed S, Rai KR. Gupta N, et al. Among authors: rai kr. Leukemia. 2002 Oct;16(10):2092-5. doi: 10.1038/sj.leu.2402676. Leukemia. 2002. PMID: 12357362
194 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback